[Pericarditis: state-of-the art and perspectives in 2025].

Abstract

Since 2015, the European Society of Cardiology's recommendations on the management of pericarditis have adapted to immunological advances. The main etiologies are viral. Diagnosis is based on clinical criteria, biological markers, ECG and cardiac imaging. Treatment combines non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, with alternative options for recurrent and refractory forms such as corticosteroids, rilonacept and anakinra. The management strategy is adjusted according to patient characteristics and imaging: MRI plays a crucial role in assessing inflammation and monitoring treatment efficacy.